Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome

Idiopathic nephrotic syndrome resistant to standard treatments remains a therapeutic dilemma in pediatric nephrology. To test whether the anti-CD20 monoclonal antibody rituximab may benefit these patients, we conducted an open-label, randomized, controlled trial in 31 children with idiopathic nephro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Magnasco, Alberto, Ravani, Pietro, Edefonti, Alberto, Murer, Luisa, Ghio, Luciana, Belingheri, Mirco, Benetti, Elisa, Murtas, Corrado, Messina, Giovanni, Massella, Laura, Porcellini, Maria Gabriella, Montagna, Michela, Regazzi, Mario, Scolari, Francesco, Ghiggeri, Gian Marco
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2012
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3358759/
https://ncbi.nlm.nih.gov/pubmed/22581994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2011080775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados